Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients.
Am J Ther
; 28(5): e592-e596, 2021 07 05.
Article
in English
| MEDLINE | ID: covidwho-1522389
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19 Drug Treatment
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Am J Ther
Journal subject:
Therapeutics
Year:
2021
Document Type:
Article
Affiliation country:
MJT.0000000000001412
Similar
MEDLINE
...
LILACS
LIS